Cargando…

Neuer Masterstudiengang: Multiple Sklerose Management

The new study program “Multiple Sclerosis Management” is aimed at physicians, therapists, nurses, scientists, pharmacists, psychologists and biologists who want to specialize in the field of multiple sclerosis (MS). After successful accreditation in 2019, the first students have been in the master’s...

Descripción completa

Detalles Bibliográficos
Autores principales: Voigt, Isabel, Stadelmann, Christine, Meuth, Sven G., Schipp, Bernhard, Flachenecker, Peter, Mäurer, Mathias, Funk, Richard H. W., Ramisch, Franziska, Niemeier, Joachim, Ziemssen, Tjalf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807678/
https://www.ncbi.nlm.nih.gov/pubmed/35107651
http://dx.doi.org/10.1007/s10354-021-00900-3
_version_ 1784643734642622464
author Voigt, Isabel
Stadelmann, Christine
Meuth, Sven G.
Schipp, Bernhard
Flachenecker, Peter
Mäurer, Mathias
Funk, Richard H. W.
Ramisch, Franziska
Niemeier, Joachim
Ziemssen, Tjalf
author_facet Voigt, Isabel
Stadelmann, Christine
Meuth, Sven G.
Schipp, Bernhard
Flachenecker, Peter
Mäurer, Mathias
Funk, Richard H. W.
Ramisch, Franziska
Niemeier, Joachim
Ziemssen, Tjalf
author_sort Voigt, Isabel
collection PubMed
description The new study program “Multiple Sclerosis Management” is aimed at physicians, therapists, nurses, scientists, pharmacists, psychologists and biologists who want to specialize in the field of multiple sclerosis (MS). After successful accreditation in 2019, the first students have been in the master’s program offered by Dresden International University (DIU) since 2020. Over a period of four semesters, it can be completed part-time and largely digitally. The master’s program is divided into six modules focusing on basics, clinical and diagnostic aspects, MS studies and statistics, disease-modifying and symptomatic therapy, disease monitoring and documentation. The teaching includes theoretical parts and numerous practical units. A further goal is to derive therapeutic intervention plans and problem-solving strategies from scientific publications and clinical studies, to develop them further and to apply them in patient care. The lecturers come from Germany, Austria and Switzerland and are predominantly professors. The German Multiple Sclerosis Society is the patron of the course. This article presents the study program in detail.
format Online
Article
Text
id pubmed-8807678
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Vienna
record_format MEDLINE/PubMed
spelling pubmed-88076782022-02-02 Neuer Masterstudiengang: Multiple Sklerose Management Voigt, Isabel Stadelmann, Christine Meuth, Sven G. Schipp, Bernhard Flachenecker, Peter Mäurer, Mathias Funk, Richard H. W. Ramisch, Franziska Niemeier, Joachim Ziemssen, Tjalf Wien Med Wochenschr Themenschwerpunkt The new study program “Multiple Sclerosis Management” is aimed at physicians, therapists, nurses, scientists, pharmacists, psychologists and biologists who want to specialize in the field of multiple sclerosis (MS). After successful accreditation in 2019, the first students have been in the master’s program offered by Dresden International University (DIU) since 2020. Over a period of four semesters, it can be completed part-time and largely digitally. The master’s program is divided into six modules focusing on basics, clinical and diagnostic aspects, MS studies and statistics, disease-modifying and symptomatic therapy, disease monitoring and documentation. The teaching includes theoretical parts and numerous practical units. A further goal is to derive therapeutic intervention plans and problem-solving strategies from scientific publications and clinical studies, to develop them further and to apply them in patient care. The lecturers come from Germany, Austria and Switzerland and are predominantly professors. The German Multiple Sclerosis Society is the patron of the course. This article presents the study program in detail. Springer Vienna 2022-02-02 2022 /pmc/articles/PMC8807678/ /pubmed/35107651 http://dx.doi.org/10.1007/s10354-021-00900-3 Text en © The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, ein Teil von Springer Nature 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Themenschwerpunkt
Voigt, Isabel
Stadelmann, Christine
Meuth, Sven G.
Schipp, Bernhard
Flachenecker, Peter
Mäurer, Mathias
Funk, Richard H. W.
Ramisch, Franziska
Niemeier, Joachim
Ziemssen, Tjalf
Neuer Masterstudiengang: Multiple Sklerose Management
title Neuer Masterstudiengang: Multiple Sklerose Management
title_full Neuer Masterstudiengang: Multiple Sklerose Management
title_fullStr Neuer Masterstudiengang: Multiple Sklerose Management
title_full_unstemmed Neuer Masterstudiengang: Multiple Sklerose Management
title_short Neuer Masterstudiengang: Multiple Sklerose Management
title_sort neuer masterstudiengang: multiple sklerose management
topic Themenschwerpunkt
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807678/
https://www.ncbi.nlm.nih.gov/pubmed/35107651
http://dx.doi.org/10.1007/s10354-021-00900-3
work_keys_str_mv AT voigtisabel neuermasterstudiengangmultiplesklerosemanagement
AT stadelmannchristine neuermasterstudiengangmultiplesklerosemanagement
AT meuthsveng neuermasterstudiengangmultiplesklerosemanagement
AT schippbernhard neuermasterstudiengangmultiplesklerosemanagement
AT flacheneckerpeter neuermasterstudiengangmultiplesklerosemanagement
AT maurermathias neuermasterstudiengangmultiplesklerosemanagement
AT funkrichardhw neuermasterstudiengangmultiplesklerosemanagement
AT ramischfranziska neuermasterstudiengangmultiplesklerosemanagement
AT niemeierjoachim neuermasterstudiengangmultiplesklerosemanagement
AT ziemssentjalf neuermasterstudiengangmultiplesklerosemanagement